CARA - Cara Therapeutic - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $6.07. This is a potential upside of $-12.18 (-66.74%) from yesterday's end of day stock price of $18.25.

Cara Therapeutic's activity chart (see below) currently has 14 price targets and 16 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 76.11% with an average time for these price targets to be met of 315 days.

Most recent stock forecast was given by SUMANT KULKARNI from CANACCORD on 13-Jun-2024. First documented stock forecast 27-Feb-2014.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 13-Jun-2024

$10

$-8.25 (-45.21%)

$23

1 years 7 months 17 days ago
(13-Jun-2024)

2/2 (100%)

$-5.97 (-37.38%)

68

Hold Since 13-Jun-2024

$7

1 years 7 months 17 days ago
(13-Jun-2024)

1/2 (50%)

$-15.36 (-68.69%)

239

Hold Since 13-Jun-2024

1 years 7 months 17 days ago
(13-Jun-2024)

1/3 (33.33%)

$-15.11 (-75.14%)

134

Hold Since 14-Nov-2023

$12

$-6.25 (-34.25%)

2 years 2 months 16 days ago
(14-Nov-2023)

1/1 (100%)

$-27.42 (-69.56%)

216

Sell

$3.5

$-1.5 (-30.00%)

$4

2 years 5 months 20 days ago
(09-Aug-2023)

4/4 (100%)

$0.48 (15.89%)

144

Show more analysts

Please expand the browser size to see the chart

What is CARA (Cara Therapeutic) average time for price targets to be met?

On average it took 315 days on average for the stock forecasts to be realized with a an average price target met ratio 76.11

Which analyst has the current highest performing score on CARA (Cara Therapeutic) with a proven track record?

ANNABEL SAMIMY

Which analyst has the most public recommendations on CARA (Cara Therapeutic)?

Annabel Samimy works at STIFEL and has 4 price targets and 8 ratings on CARA

Which analyst is the currently most bullish on CARA (Cara Therapeutic)?

Chris Howerton with highest potential upside - $35.38

Which analyst is the currently most reserved on CARA (Cara Therapeutic)?

Sumant Kulkarni with lowest potential downside - -$8.25

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?